The prevalence of atrial fibrillation (AF) is substantial and increasing. Stroke is common in AF and can have devastating consequences. Oral anticoagulants are effective in reducing stroke risk, but are underutilized.
We sought to characterize the impact of stroke on AF patients and their caregivers, gaps in knowledge and perspective between physicians and patients, and barriers to effective communication and optimal anticoagulation use.
A survey was administered to AF patients with and without history of stroke, caregivers of stroke survivors, and physicians across the range of specialties caring for AF and stroke patients.
While AF patients (n = 499) had limited knowledge about stroke, they expressed great desire to learn more and take action to reduce their risk. They were often dissatisfied with the education they had received and desired high-quality written materials. Stroke survivors (n = 251) had poor functional outcomes and often underestimated the burden of caring for them. Caregivers (n = 203) also wished they had received more information about reducing stroke risk before their survivor's event. They commonly felt overwhelmed and socially isolated. Physicians (n = 504) did not prescribe anticoagulants as frequently as recommended by guidelines. Concerns about monitoring anticoagulation and patient compliance were commonly reported barriers. Physicians may underestimate patient willingness to take anticoagulants.
We identified significant knowledge gaps among patients, caregivers, and physicians in relation to AF and stroke. Furthermore, gaps in perspective often lead to suboptimal communication and decision making. Increased education and better communication between all stakeholders are needed to reduce the impact of stroke in AF.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Stroke and Cerebrovascular Diseases
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.Circulation. 2014; 129: 837-847
- Increasing prevalence of atrial fibrillation and flutter in the United States.Am J Cardiol. 2009; 104: 1534-1539
- Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.Circulation. 2004; 110: 1042-1046
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke. 1991; 22: 983-988
- The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg.Am J Geriatr Cardiol. 2005; 14: 56-61
- Stroke severity in atrial fibrillation: the Framingham Study.Stroke. 1996; 27: 1760-1764
- Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (the European Community Stroke Project).Stroke. 2001; 32: 392-398
- Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.JAMA. 2002; 288: 2441-2448
- Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.N Engl J Med. 2003; 349: 1019-1026
- Underuse of oral anticoagulants in atrial fibrillation: a systematic review.Am J Med. 2010; 123 (e634): 638-645
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation.Chest. 2010; 137: 263-272
- Prevalence and knowledge of transient ischemic attack among US adults.Neurology. 2003; 60: 1429-1434
- Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment.Stroke. 2009; 40: 2502-2506
- Knowledge of stroke risk factors and warning signs among Michigan adults.Neurology. 2002; 59: 1547-1552
- Stroke literacy in Central Harlem: a high-risk stroke population.Neurology. 2009; 73: 1950-1956
- Barriers to acute stroke therapy and stroke prevention in Mexican Americans.Stroke. 2001; 32: 1360-1364
- Child-Mediated Stroke Communication: findings from Hip Hop Stroke.Stroke. 2012; 43: 163-169
- Public awareness of stroke in Korea: a population-based national survey.Stroke. 2012; 43: 1146-1149
- Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population.Stroke. 2001; 32: 1926-1930
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.J Am Coll Cardiol. 2014; 64: e1-e76
- Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.CMAJ. 2001; 165: 301-302
- Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.Eur Heart J. 2006; 27: 3018-3026
- Dabigatran versus warfarin in patients with atrial fibrillation.N Engl J Med. 2009; 361: 1139-1151
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med. 2011; 365: 883-891
- Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2011; 365: 981-992
- Edoxaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2013; 369: 2093-2104
- Stroke-related knowledge and health behaviors among poststroke patients in inpatient rehabilitation.Arch Phys Med Rehabil. 2007; 88: 1214-1216
- Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA.Eur J Neurol. 2009; 16: 678-683
- Knowledge of stroke risk factors among primary care patients with previous stroke or TIA: a questionnaire study.BMC Fam Pract. 2010; 11: 47
- Knowledge gaps in stroke care: results of a survey of family physicians in Pakistan.J Stroke Cerebrovasc Dis. 2011; 20: 282-286
- Bias in case-control studies: a review.J Epidemiol Community Health. 1990; 44: 179-186
- Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.Ann Intern Med. 2000; 133: 21-30
- Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance.J Hypertens Suppl. 1985; 3: S51-S55
- A literature review on the efficacy of video in patient education.J Med Educ. 1988; 63: 785-792
- Stroke awareness and knowledge retention in children: the Brain Child Project.Stroke. 2002; 33: 623-625
The survey administration was supported by Boehringer Ingelheim. Dr Gorelick serves on the speaker's bureau for stroke prevention in atrial fibrillation sponsored by Boehringer Ingelheim and Pfizer.
Abbreviations: AF, atrial fibrillation; TIA, transient ischemic attack.
© 2015 Heart Rhythm Society and National Stroke Association. Published by Elsevier Inc. All rights reserved.